Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Announces Brokered LIFE Financing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(340)
•••
Comment by BudFoxx2020on Oct 27, 2023 3:23pm
149 Views
Post# 35704791

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

is this guy that dumb.  Once again threats.  Lololol.  I am saying the company should look into you trumpy and your grou for the baseless pumping.  The company never mentioned anything about billions or $100 in share price.  It is you.  Wonder why you would continue to make theee baseless claims.  I wonder what your intentions are.  The company should look into uoi and your trading in TLT.  Lolololol.  What a clown.  Have a great weekend all.  Be diligent we are in a bear market.  Cheers.


TriumphSpitSix wrote: I highly suggest reporting this post under the category "Defamatory Statements." Feel free to use the description I included in my report or amend to your liking:

"This is libel. Poster accuses the company, without evidence, of paying bullboard members to post false messages as part of a scheme to defraud investors."


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities